Cargando…

The prevalence of clarithromycin-resistant Helicobacter pylori isolates: a systematic review and meta-analysis

BACKGROUND: Knowledge of global clarithromycin (CLA)-resistant rates of Helicobacter pylori (H. pylori) is crucial for decision of the most appropriate eradication therapies with good clinical outcomes. Therefore, this review and meta-analysis aimed to evaluate the global prevalence of the CLA resis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sholeh, Mohammad, Khoshnood, Saeed, Azimi, Taher, Mohamadi, Jasem, Kaviar, Vahab Hassan, Hashemian, Marzieh, Karamollahi, Somayeh, Sadeghifard, Nourkhoda, Heidarizadeh, Hedayat, Heidary, Mohsen, Saki, Morteza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2023
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066884/ https://www.ncbi.nlm.nih.gov/pubmed/37016679 http://dx.doi.org/10.7717/peerj.15121

Ejemplares similares

Molecular typing and antibiotic resistance patterns among clinical isolates of Acinetobacter baumannii recovered from burn patients in Tehran, Iran
por: Maleki, Abbas, et al.
Publicado: (2022)

Amoxicillin-docosahexaenoic acid encapsulated chitosan-alginate nanoparticles as a delivery system with enhanced biocidal activities against Helicobacter pylori and improved ulcer healing
por: Khoshnood, Saeed, et al.
Publicado: (2023)

Mechanism of Action, Resistance, Synergism, and Clinical Implications of Delamanid Against Multidrug-Resistant Mycobacterium tuberculosis
por: Khoshnood, Saeed, et al.
Publicado: (2021)

Heteroresistance to clarithromycin and metronidazole in patients with a Helicobacter pylori infection: a systematic review and meta-analysis
por: Kouhsari, Ebrahim, et al.
Publicado: (2022)

The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis
por: Shirani, Maryam, et al.
Publicado: (2023)

Clinical, epidemiological, laboratory, and radiological characteristics of novel Coronavirus (2019-nCoV) in retrospective studies: A systemic review and meta-analysis
por: Kouhsari, Ebrahim, et al.
Publicado: (2021)

Linezolid resistance in multidrug-resistant mycobacterium tuberculosis: A systematic review and meta-analysis
por: Azimi, Taher, et al.
Publicado: (2022)

Viral vector and nucleic acid vaccines against COVID-19: A narrative review
por: Khoshnood, Saeed, et al.
Publicado: (2022)

A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19
por: Heidary, Mohsen, et al.
Publicado: (2022)

Effect of ZnO nanoparticles on biofilm formation and gene expression of the toxin-antitoxin system in clinical isolates of Pseudomonas aeruginosa
por: Valadbeigi, Hassan, et al.
Publicado: (2023)

Obesity and gut–microbiota–brain axis: A narrative review
por: Asadi, Arezoo, et al.
Publicado: (2022)

Persister cells as a possible cause of antibiotic therapy failure in Helicobacter pylori
por: Bahmaninejad, Parvin, et al.
Publicado: (2021)

Replacement of clarithromycin with azithromycin in triple therapy regimens for the eradication of helicobacter pylori: A randomized clinical trial
por: Khoshnood, A, et al.
Publicado: (2014)

Antimicrobial resistance and biofilm formation capacity among Acinetobacter baumannii strains isolated from patients with burns and ventilator‐associated pneumonia
por: Khoshnood, Saeed, et al.
Publicado: (2022)

Genotypic and Phenotypic Resistance to Clarithromycin in Helicobacter pylori Strains
por: Gong, Eun Jeong, et al.
Publicado: (2020)

Early genetic diagnosis of clarithromycin resistance in Helicobacter pylori
por: Li, Xiao-Hua, et al.
Publicado: (2021)

Molecular Characterization of Clarithromycin Resistance in Helicobacter pylori Strains
por: Örsten, Serra, et al.
Publicado: (2023)

The Comparison of Levofloxacin- and Clarithromycin-Based Bismuth Quadruple Therapy Regimens in Helicobacter pylori Eradication
por: Arj, Abbas, et al.
Publicado: (2020)

Comparison of Azithromycin and Clarithromycin Triple Therapy Regimens for Helicobacter Pylori Eradication in Hemodialysis Patients
por: Jalalzadeh, Mojgan, et al.
Publicado: (2012)

Complete Genome Sequences of Helicobacter pylori Clarithromycin-Resistant Strains
por: Binh, Tran Thanh, et al.
Publicado: (2013)

A Novel Reduction Strategy of Clarithromycin Resistance in Helicobacter pylori
por: Tadjrobehkar, Omid, et al.
Publicado: (2014)

Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori
por: Feng, Zi-Han, et al.
Publicado: (2019)

Is Only Clarithromycin Susceptibility Important for the Successful Eradication of Helicobacter pylori?
por: Kim, Young Min, et al.
Publicado: (2020)

An overview on inactivated and live‐attenuated SARS‐CoV‐2 vaccines
por: Khoshnood, Saeed, et al.
Publicado: (2022)

Comparison of levofloxacin versus clarithromycin efficacy in the eradication of Helicobacter pylori infection
por: Haji-Aghamohammadi, Ali Akbar, et al.
Publicado: (2016)

Trends in Helicobacter pylori resistance to clarithromycin: from phenotypic to genomic approaches
por: Marques, Andreia T., et al.
Publicado: (2020)

A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance
por: Adachi, Kazunori, et al.
Publicado: (2023)

Variability in Prevalence of Helicobacter pylori Strains Resistant to Clarithromycin and Levofloxacin in Southern Poland
por: Karczewska, Elżbieta, et al.
Publicado: (2012)

Mutations in the 23S rRNA gene of Helicobacter pylori associated with clarithromycin resistance.
por: Kim, Kyung Suk, et al.
Publicado: (2002)

Impact of Helicobacter pylori Biofilm Formation on Clarithromycin Susceptibility and Generation of Resistance Mutations
por: Yonezawa, Hideo, et al.
Publicado: (2013)

Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran
por: Khademi, Farzad, et al.
Publicado: (2013)

Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national survey
por: Sanches, Bruno Squarcio, et al.
Publicado: (2016)

Antimicrobial susceptibility and clarithromycin resistance patterns of Helicobacter pylori clinical isolates in Vietnam
por: Quek, Camelia, et al.
Publicado: (2016)

Clarithromycin versus Gemifloxacin in Quadruple Therapeutic Regimens for Helicobacter Pylori Infection Eradication
por: Mansour-Ghanaei, Fariborz, et al.
Publicado: (2017)

Clarithromycin-Susceptible But Virulent Helicobacter pylori Strains Infecting Iranian Patients’ Stomachs
por: Khani, Shadiyeh, et al.
Publicado: (2019)

Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides
por: Kocsmár, Éva, et al.
Publicado: (2021)

Benefits of a Molecular-Based Method for the Detection of Clarithromycin-Resistant Helicobacter pylori
por: Saruuljavkhlan, Batsaikhan, et al.
Publicado: (2021)

Helicobacter pylori Virulence Factors and Clarithromycin Resistance-Associated Mutations in Mexican Patients
por: Alarcón-Millán, Judit, et al.
Publicado: (2023)

Combating multidrug-resistant Helicobacter pylori with moenomycin A in combination with clarithromycin or metronidazole
por: Tseng, Yen-Yu, et al.
Publicado: (2022)

Real-Time Polymerase Chain Reaction for the Detection of Helicobacter pylori and Clarithromycin Resistance
por: Noh, Jin Hee, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_328paj7dg4vt8lfd8mkkhm9kp2